Anand Rathi Share & Stock Brokers IPO Day 3: Check GMP, Subscription Status & Key Highlights
The bidding window for the ₹745 crore Anand Rathi Share & Stock Brokers IPO will conclude today. Till the end of Day 2, the IPO was subscribed to a total of 1.11 times.
Anand Rathi Share & Stock Brokers IPO: Issue Details
- Issue Size: Anand Rathi Share & Stock Brokers IPO is a book-building issue of ₹745 crores, consisting entirely of a fresh issue of 1.80 crore shares.
- Price Band: The price band is set between ₹393 and ₹414 per share.
- Book-running lead managers: Nuvama Wealth Management Limited, DAM Capital Advisors Limited, and Anand Rathi Advisors Limited.
- Registrar: MUFG Intime India Private Limited
- Listing: The shares are proposed to be listed on the NSE and BSE on September 30.
Anand Rathi Share & Stock Brokers IPO Day 3: Subscription Details
[25-September-2025 10:06:00]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.01 |
|
Non-Institutional Investors |
1.36 |
|
Retail Individual Investors (RIIs) |
0.82 |
|
Employees |
0.39 |
|
Total |
0.70 |
Utilisation of IPO Proceeds
The company aims to use the net proceeds from the fresh issue towards the following objectives.
- Fund long-term working capital requirements
- General corporate purposes
Anand Rathi Share & Stock Brokers IPO GMP Details
As of 25 September 2025, the GMP of Anand Rathi Share & Stock Brokers' IPO stood at ₹35. The estimated listing price is ₹449, i.e., an 8.45% gain per share over the upper price band.
Source: Business Standard Report dated 25 September 2025
|
Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.